`

Synaffix BV

Biotechnology Research

Specialities :
Antibody-drug conjugates (adcs)
Cell engagers
Targeted gene therapy
And bispecific antibodies
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Synaffix BV

What does Synaffix bv do?+

Synaffix BV is a biotech company that has established a proprietary, clinical-stage antibody-drug conjugate (ADC) technology platform that delivers best-in-class ADCs (safety and efficacy). Our platform is commercially validated by well over $7.6 billion in technology out-licensing deals with partners including ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio and Kyowa Kirin. These partnerships have rapidly translated Synaffix technology into >20 ADCs currently in development by our partners, where 5 of these have already initiated Phase 1 clinical trials. Through the platform, we can rapidly generate best-in-class ADCs for our partners from any antibody and our patent portfolio protects...

What are Synaffix bv's specialties? +

Antibody-drug conjugates (adcs),cell engagers,targeted gene therapy,and bispecific antibodies

What is Synaffix bv's industry? +

Synaffix bv operates in the Biotechnology research industry.

What is Synaffix bv's revenue? +

Synaffix bv's revenue is 11m - 100m

What is Synaffix bv's company size? +

Synaffix bv has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.